HomeBusiness & MoneyEli Lilly Stock Slips as Hyped-Up Obesity Drug Sales Fall Short. Earnings...
Business & Money

Eli Lilly Stock Slips as Hyped-Up Obesity Drug Sales Fall Short. Earnings Still Crushed.

MK
By MK
0
9




Eli Lilly


stock was falling Thursday as sales in the pharmaceutical company’s much-hyped obesity drug came up short. Fourth-quarter earnings, however, did crush estimates.

Shares in


Eli Lilly


(ticker: LLY) fell 2.9% in premarket trading. Futures tracking the


S&P 500


were rising 0.5%, by comparison.



Source link

Previous article
Why have there been no named winter storms this year?
Next article
Bitzlato to Restore Operations and Withdrawals From Russia, Co-founder Vows – Exchanges Bitcoin News
MK
MKhttps://okbroadcast.com
RELATED ARTICLES

Most Popular

Load more

Recent Comments

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

This website, OkBroadcast.com, gathers all information from publicly accessible sources without making any modifications to the content or source. The original source for each news item is clearly indicated. Our channel provides news, information, and entertainment without any bias, presenting the latest breaking news and videos from the entertainment industry. We obtain our information from RSS feeds and other available sources, and we also create and commission original content in print and video formats, including our own YouTube channel, "VIAYT." We hope you enjoy the diverse range of topics and subjects presented in a constantly evolving world..

Contact us: info@oamericans.com

FOLLOW US

© OkBroadcast.com, The News, Information % Entertainment Bureau.